Generic Name and Formulations:
Levofloxacin (as hemihydrate) 0.5%; oph. soln; contains benzalkonium chloride.
Vistakon Pharmaceuticals, LLC
Indications for QUIXIN:
Susceptible bacterial conjunctivitis.
Adults and Children:
<1yr: not recommended. ≥1yr: 1–2 drops in affected eye(s) every 2 hours while awake (max 8 times/day) on days 1 and 2, then 1–2 drops every 4 hours while awake (max 4 times/day) on days 3–7.
Discontinue if superinfection or hypersensitivity occurs. Pregnancy (Cat.C). Nursing mothers.
May potentiate theophylline, caffeine, oral anticoagulants. May cause elevated serum creatinine with cyclosporine.
Transient decreased vision, ocular burning, pain or discomfort, fever, foreign body sensation, headache, pharyngitis, photophobia.
Endocrinology Advisor Articles
- Single Blood Sample Highly Predictive for Subsequent Diabetes Diagnosis
- Adjunctive Metformin for Insulin Resistance in T1D: A Clinical Perspective
- Effect of Fructose, Allulose on Postprandial Glucose Regulation in Type 2 Diabetes
- Sex Hormone Levels May Affect Postmenopausal Heart Disease Risk
- Menopausal Hormone Therapy Slows Cognitive Decline in Postmenopausal Women
- Diabetes Treatments
- Metformin May Decrease Colorectal Cancer Risk Among Males With Diabetes
- SGLT2 Inhibitor, GLP-1 Receptor Agonist Combination Treatment for Type 2 Diabetes: Expert Insights
- Semaglutide May Induce Weight Loss in Type 2 Diabetes Despite BMI
- FDA Clears Omnipod DASH System for Diabetes Management
- Effect of Infant Feeding Practices and Gut Microbiota on Overweight in First Year
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Cleared Blood Glucose Monitor Systems Not Always Accurate
- CDC: Obesity Prevalence Higher in Non-Metropolitan Counties
- Vascular Mortality Declining in Adults With Diabetes in the United States